MedTrace Logo

Efficacy and Tolerability of Venoactive Drugs in Patients With Chronic Venous Diseases C4a&b in Real Clinical Practice.

NCT04138576 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 381

Last updated 2023-09-01

Study results available
· View outcomes & findings →

Summary

The study is aimed at evaluating the efficacy and tolerability of systemic pharmacotherapy as a part of combination treatment, and its influence on the overall treatment outcomes in patients with skin changes (CEAP class C4a and C4b).

Conditions

  • Chronic Venous Diseases

Sponsors & Collaborators

  • Servier Russia

    lead INDUSTRY

Principal Investigators

  • Olga Linnik · Medical manager

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-12-25
Primary Completion
2020-10-01
Completion
2020-12-01

Countries

  • Russia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04138576 on ClinicalTrials.gov